K. M, S. D, B. H, T. M, K. I, T. Y, H. M, B. K, Koné D, K. A, D. M, Touré D, Diarra A S, D. F, D. O, Traoré Fd
{"title":"巴马科区第五社区 Csref 中乙型肝炎抗体阳性的新生儿母亲的乙型肝炎传播情况","authors":"K. M, S. D, B. H, T. M, K. I, T. Y, H. M, B. K, Koné D, K. A, D. M, Touré D, Diarra A S, D. F, D. O, Traoré Fd","doi":"10.36348/sjmps.2024.v10i05.001","DOIUrl":null,"url":null,"abstract":"The main cause of chronic HBsAg carriage is mother-to-child transmission. The aim of the study was to determine the epidemiological, clinical and biological aspects of mother-to-child transmission of the hepatitis B virus in newborns of HBsAg-positive mothers. Methodology: This was a descriptive cross-sectional study which took place from 1 March 2020 to 30 June 2021 at the CSREF in Commune V. Sampling was exhaustive, and all newborns whose mothers were carriers of hepatitis B were included in the study. Results: One hundred and twenty newborns out of 3197 referred from the maternity unit, representing a frequency of 3.7% of hepatitis B in pregnant women. Eighty newborns were included. The other 40 were not included because the mothers refused. Among the mothers, 11/80 tested positive for HBeAg and anti-HBs, with 2 positive results (18.18%). Twelve pregnant women had viral load tests, with two positive results (16.66%). Six of the 80 pregnant women had received tenofovir during pregnancy (7.5%), and all the newborns had negative HBsAg results at 4 months of age. Conclusion : Low realization of viral markers of hepatitis B and treatment during pregnancy.","PeriodicalId":21367,"journal":{"name":"Saudi Journal of Medical and Pharmaceutical Sciences","volume":" 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Transmission of Hepatitis B in Newborn Mothers with Positive Hbs in the Csref of Commune V of the District of Bamako\",\"authors\":\"K. M, S. D, B. H, T. M, K. I, T. Y, H. M, B. K, Koné D, K. A, D. M, Touré D, Diarra A S, D. F, D. O, Traoré Fd\",\"doi\":\"10.36348/sjmps.2024.v10i05.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The main cause of chronic HBsAg carriage is mother-to-child transmission. The aim of the study was to determine the epidemiological, clinical and biological aspects of mother-to-child transmission of the hepatitis B virus in newborns of HBsAg-positive mothers. Methodology: This was a descriptive cross-sectional study which took place from 1 March 2020 to 30 June 2021 at the CSREF in Commune V. Sampling was exhaustive, and all newborns whose mothers were carriers of hepatitis B were included in the study. Results: One hundred and twenty newborns out of 3197 referred from the maternity unit, representing a frequency of 3.7% of hepatitis B in pregnant women. Eighty newborns were included. The other 40 were not included because the mothers refused. Among the mothers, 11/80 tested positive for HBeAg and anti-HBs, with 2 positive results (18.18%). Twelve pregnant women had viral load tests, with two positive results (16.66%). Six of the 80 pregnant women had received tenofovir during pregnancy (7.5%), and all the newborns had negative HBsAg results at 4 months of age. Conclusion : Low realization of viral markers of hepatitis B and treatment during pregnancy.\",\"PeriodicalId\":21367,\"journal\":{\"name\":\"Saudi Journal of Medical and Pharmaceutical Sciences\",\"volume\":\" 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Saudi Journal of Medical and Pharmaceutical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36348/sjmps.2024.v10i05.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Journal of Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/sjmps.2024.v10i05.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Transmission of Hepatitis B in Newborn Mothers with Positive Hbs in the Csref of Commune V of the District of Bamako
The main cause of chronic HBsAg carriage is mother-to-child transmission. The aim of the study was to determine the epidemiological, clinical and biological aspects of mother-to-child transmission of the hepatitis B virus in newborns of HBsAg-positive mothers. Methodology: This was a descriptive cross-sectional study which took place from 1 March 2020 to 30 June 2021 at the CSREF in Commune V. Sampling was exhaustive, and all newborns whose mothers were carriers of hepatitis B were included in the study. Results: One hundred and twenty newborns out of 3197 referred from the maternity unit, representing a frequency of 3.7% of hepatitis B in pregnant women. Eighty newborns were included. The other 40 were not included because the mothers refused. Among the mothers, 11/80 tested positive for HBeAg and anti-HBs, with 2 positive results (18.18%). Twelve pregnant women had viral load tests, with two positive results (16.66%). Six of the 80 pregnant women had received tenofovir during pregnancy (7.5%), and all the newborns had negative HBsAg results at 4 months of age. Conclusion : Low realization of viral markers of hepatitis B and treatment during pregnancy.